Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Clinical Lymphoma, Myeloma & Leukemia|June 8, 2023
Culturally Responsive Care Delivery in Oncology: The Example of Multiple MyelomaBrandon Blue, Amy Pierre, Joseph MikhaelCureus|September 27, 2018
Impact of an Inpatient Palliative Care Consultation in Terminally Ill Cancer PatientsBrandon Blue, Radhakrishna Vegunta, Miriam Rodin, et al.Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|May 30, 2026
Understanding Physician Referral for Chimeric Antigen Receptor T-Cell (CAR-T) TherapyBrandon Blue, Paige Lake, Joseph Pidala, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2016
Statins Are Associated With Reduced Mortality in Multiple MyelomaKristen Marie Sanfilippo, Jesse Keller, Brian F Gage, et al.Clinical Lymphoma, Myeloma & Leukemia|May 3, 2022
Adding Cyclophosphamide to Bortezomib and Dexamethasone was not Associated With Improved Outcomes of Patients With Newly Diagnosed Light Chain Amyloidosis: A Retrospective StudyYumeng Zhang, Lauren Duncanson, Jason Brayer, et al.Proceedings of the National Academy of Sciences of the United States of America|January 13, 2025
Hydrated cable bacteria exhibit protonic conductivity over long distancesBradley G Lusk, Sheba Morgan, Shawn P Mulvaney, et al.Frontiers in Oncology|November 12, 2025
Post-progression outcomes following BCMA-directed CAR T-cell therapy in myeloma: impact of extramedullary and paramedullary diseaseZiad Abuhelwa, Fnu Amisha, Wenyi Fan, et al.Nature Communications|January 9, 2020
Enabling remote quantum emission in 2D semiconductors via porous metallic networksJose J Fonseca, Andrew L Yeats, Brandon Blue, et al.Journal of Geriatric Oncology|September 18, 2023
Safety and efficacy of anti-BCMA CAR-T cell therapy in older adults with multiple myeloma: A systematic review and meta-analysisOthman Salim Akhtar, Ba Aqeel Sheeba, Farhan Azad, et al.Blood Advances|May 2, 2022
Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myelomaLauren C Peres, Christelle M Colin-Leitzinger, Mingxiang Teng, et al.Pageof 2